Her-2 expression in cutaneous eccrine and apocrine neoplasms

Modern Pathology

Volumn 17, Issue 1, 2004, Pages 28-32

  Hiatt, Kim M ^a   Pillow, Jessica L ^a   Smoller, Bruce R ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Cutaneous apocrine neoplasm; Cutaneous eccrine neoplasms; HER 2 neu; Histochemistry; Metastatic breast carcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

APOCRINE CARCINOMA; ARTICLE; BREAST METASTASIS; CONTROLLED STUDY; HIDRADENOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; SWEAT GLAND CARCINOMA;

ADENOMA, SWEAT GLAND; APOCRINE GLANDS; BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; ECCRINE GLANDS; FEMALE; HIDROCYSTOMA; HUMANS; NEOPLASMS, ADNEXAL AND SKIN APPENDAGE; PREDICTIVE VALUE OF TESTS; RECEPTOR, ERBB-2; REPRODUCIBILITY OF RESULTS; SWEAT GLAND NEOPLASMS;

EID: 3042612140     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800007     Document Type: Article

References (19)

1. Cole R, Kemp B, Ziesmer S, et al. Detection of Mammaglobin gene (hMAM) expression by mammaglobin 967 in cutaneous metastatic mammary and non-mammary epithelial carcinomas and benign and malignant appendageal tumors [abstract]. American Society of Dermatopathology Annual Meeting 2002.
2. Wallace M, Longacre T, Smoller B. Estrogen and progesterone receptors and anti-gross cystic disease gluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms. Mod pathol 1995;8:897-901.
3. Busam KJ, Tan LK, Granter SR, et al. Epidermal growth factor, estrogen, and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas. Mod Pathol 1999;12:786-793.
4. Wick MR, Ockner DM, Mills SE, et al. Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma. Am J Clin Pathol 1998;109:75-84.
5. Ormsby AH, Snow JL, Su WP, et al. Diagnostic immunohistochemistry of cutaneous metastatic breast carcinoma: a statistical analysis of the utility of gross cystic disease fluid protein-15 and estrogen receptor protein. J Am Acad Dermatol 1995;32:711-716.
6. De Potter CR, Schelfhout AM. The neu-protein and breast cancer. Virchows Arch 1995;426:107-115.
7. Carraway KL, Perez A, Idris N, et al. Muc4/sialomucin complex, the intramembrane ErbB2 ligand, in cancer and epithelia: to protect and to survive. Prog Nucleic Acid Res Mol Biol 2002;71:149-185.
8. Maguire Jr HC, Jaworsky C, Cohen JA, et al. Distribution of neu (c-erbB-2) protein in human skin. J Invest Dermatol 1989;92:786-790.
9. Kaptain S, Tan LK, Chen B. Her-2/neu and breast cancer. Diagn Mol Pathol 2001;10:139-152.
10. Gao D, Lu Y, Wang Y, et al. Significance of HER-2/neu expression in ovarian epithelial tumours. Zhonghua Bing Li Xue Za Zhi 2002;31:268-270.
11. Zhou H, Randall R, Brothman A, et al. Her-2/neu expression in osteosarcoma increases risk of lung metastasis and can be associated with gene amplification. J Pediatric Hematol Oncol 2003;25:27-32.
12. Kruger S, Weitsch G, Buttner H, et al. HER2 overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic implications. Int J Cancer 2002;102:514-518.
13. Sanchez KM, Sweeney CJ, Mass R, et al. Evaluation of HER-2/neu expression in prostatic adenocarcinoma: a request for a standardized, organ specific methodology. Cancer 2002;95:1650-1655.
14. Sirica AE, Lai GH, Endo K, et al. Cyclooxygenase-2 and ERBB-2 in cholangiocarcinoma: potential therapeutic targets. Semin Liver Dis 2002;22:303-313.
15. Forseen S, Potti A, Koka V, et al. Identification and relationship of HER-2/neu overexpression to short-term mortality in primary malignant brain tumors. Anticancer Res 2002;22:1599-1602.
16. Knosel T, Yr Y, Stein U, et al. Overexpression of c-erbB-2 protein correlates with chromosomal gain at the c-erbB-2 locus and patient survival in advanced colorectal carcinomas. Clin Exp Metast 2002;19:401-471.
17. Smith KJ, Williams J, Corbett D, et al. Microcystic adnexal carcinoma: an immunohistochemical study including markers of proliferation and apoptosis. Am J Surg Pathol 2001;25:464-471.
18. Simon R, Nocito A, Hubscher T, et al. Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer. J Natl Cancer Inst 2001;93:1141-1146.
19. Tanner M, Jarvinen P, Isola J. Amplification of HER-2/neu and topoisomerase II alpha in primary and metastatic breast cancer. Cancer Res 2001;61:5345-5348.